Xuan Wang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Xuan Wang has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
Chaojie Wang
Department of Fist Clinical Medical College, Heilongjiang University of Chinese Medicine, Harbin, China
1 shared publicationCiai Yan
Department of Fist Clinical Medical College, Heilongjiang University of Chinese Medicine, Harbin, China
1 shared publicationHua Cui
Department of Fist Clinical Medical College, Heilongjiang University of Chinese Medicine, Harbin, China
1 shared publication- Peiyao Meng
Graduate School, Heilongjiang University of Chinese Medicine, Harbin, Heilongjiang Province, China
1 shared publication - Qi Zhang
Center for Preventive Treatment of Disease, First Affiliated Hospital, Heilongjiang University of Chinese Medicine, Harbin, Heilongjiang Province, China
1 shared publication - Wei-Ping Cheng
Department of Research Centre of Translational Medicine of Traditional Chinese Medicine, The First Affiliated Hospital of Heilongjiang University of Chinese Medicine, Harbin, Heilongjiang Province, PR China
1 shared publication
Latest Publications
- Open Access
- 28 November 2025
- Published by Wolters Kluwer Health in Medicine
- Vol. 104 (48) , e46110
Advances in acupuncture modulation of signaling pathways for epilepsy treatment: A review
This study presents a comprehensive review and analysis of global research progress over the past 2 decades regarding the molecular mechanisms underlying acupuncture therapy for epilepsy. Our findings demonstrate that acupuncture, through single or combined acupoint stimulation (including but not limited to GV14, GV20, GV24, ST36, LI11, and ST37), exerts antiepileptic effects primarily by modulating key signaling pathways: PI3K/Akt, TLR4, NF-κB, mTOR, MAPK, BDNF/TrkB, and Nrf2/ARE/HO-1. The therapeutic mechanisms involve suppression of neuroinflammation, mitigation of oxidative stress, inhibition of neuronal apoptosis, regulation of neurotransmitter balance, and restoration of synaptic plasticity, collectively contributing to the reestablishment of excitation/inhibition homeostasis in the central nervous system. These findings establish an “acupoint-pathway-effect” regulatory network, highlighting acupuncture’s unique advantage as a multi-target, multi-level therapeutic approach for epilepsy management.
- 28 November 2025
- Published by Wolters Kluwer Health in Medicine
- Vol. 104 (48) , e46110
Open AccessAdvances in acupuncture modulation of signaling pathways for epilepsy treatment: A review
This study presents a comprehensive review and analysis of global research progress over the past 2 decades regarding the molecular mechanisms underlying acupuncture therapy for epilepsy. Our findings demonstrate that acupuncture, through single or combined acupoint stimulation (including but not limited to GV14, GV20, GV24, ST36, LI11, and ST37), exerts antiepileptic effects primarily by modulating key signaling pathways: PI3K/Akt, TLR4, NF-κB, mTOR, MAPK, BDNF/TrkB, and Nrf2/ARE/HO-1. The therapeutic mechanisms involve suppression of neuroinflammation, mitigation of oxidative stress, inhibition of neuronal apoptosis, regulation of neurotransmitter balance, and restoration of synaptic plasticity, collectively contributing to the reestablishment of excitation/inhibition homeostasis in the central nervous system. These findings establish an “acupoint-pathway-effect” regulatory network, highlighting acupuncture’s unique advantage as a multi-target, multi-level therapeutic approach for epilepsy management.
- Open Access
- 3 October 2024
- Published by Frontiers Media SA in Frontiers in Molecular Neuroscience
- Vol. 17, 1454780
A review of the pathogenesis of epilepsy based on the microbiota-gut-brain-axis theory
The pathogenesis of epilepsy is related to the microbiota-gut-brain axis, but the mechanism has not been clarified. The microbiota-gut-brain axis is divided into the microbiota-gut-brain axis (upward pathways) and the brain-gut-microbiota axis (downward pathways) according to the direction of conduction. Gut microorganisms are involved in pathological and physiological processes in the human body and participate in epileptogenesis through neurological, immunological, endocrine, and metabolic pathways, as well as through the gut barrier and blood brain barrier mediated upward pathways. After epilepsy, the downward pathway mediated by the HPA axis and autonomic nerves triggers “leaky brain “and “leaky gut,” resulting in the formation of microbial structures and enterobacterial metabolites associated with epileptogenicity, re-initiating seizures via the upward pathway. Characteristic changes in microbial and metabolic pathways in the gut of epileptic patients provide new targets for clinical prevention and treatment of epilepsy through the upward pathway. Based on these changes, this review further redescribes the pathogenesis of epilepsy and provides a new direction for its prevention and treatment.
- 3 October 2024
- Published by Frontiers Media SA in Frontiers in Molecular Neuroscience
- Vol. 17, 1454780
Open AccessA review of the pathogenesis of epilepsy based on the microbiota-gut-brain-axis theory
The pathogenesis of epilepsy is related to the microbiota-gut-brain axis, but the mechanism has not been clarified. The microbiota-gut-brain axis is divided into the microbiota-gut-brain axis (upward pathways) and the brain-gut-microbiota axis (downward pathways) according to the direction of conduction. Gut microorganisms are involved in pathological and physiological processes in the human body and participate in epileptogenesis through neurological, immunological, endocrine, and metabolic pathways, as well as through the gut barrier and blood brain barrier mediated upward pathways. After epilepsy, the downward pathway mediated by the HPA axis and autonomic nerves triggers “leaky brain “and “leaky gut,” resulting in the formation of microbial structures and enterobacterial metabolites associated with epileptogenicity, re-initiating seizures via the upward pathway. Characteristic changes in microbial and metabolic pathways in the gut of epileptic patients provide new targets for clinical prevention and treatment of epilepsy through the upward pathway. Based on these changes, this review further redescribes the pathogenesis of epilepsy and provides a new direction for its prevention and treatment.